4.7 Article

Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51

Alanna R. Kaplan et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Medicine, General & Internal

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Talia Golan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Oncology

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

Bella Kaufman et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Multidisciplinary Sciences

Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130

Denise Campisi Hegan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Oncology

BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma

Cristina R. Ferrone et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Medicine, General & Internal

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.

Peter C. Fong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Oncology

Hypoxia-induced down-regulation of BRCA1 expression by E2Fs

RS Bindra et al.

CANCER RESEARCH (2005)

Article Biochemistry & Molecular Biology

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells

RS Bindra et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)